BIX0:F BIOINVENT INTERN. SK 2

EUR 2.00 -0.01 -0.448878
Icon

BIOINVENT INTERN. SK 2 (BIX0:F) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | F
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 2.00

-0.01 (-0.45)%

EUR 0.13B

6.00

N/A

N/A

Icon

BIX0:F

BIOINVENT INTERN. SK 2 (EUR)
COMMON STOCK | F
EUR 2.00
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.13B

N/A

EUR 2.00

BIOINVENT INTERN. SK 2 (BIX0:F) Stock Forecast

N/A

Based on the BIOINVENT INTERN. SK 2 stock forecast from 0 analysts, the average analyst target price for BIOINVENT INTERN. SK 2 is not available over the next 12 months. BIOINVENT INTERN. SK 2’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of BIOINVENT INTERN. SK 2 is Slightly Bearish, which is based on 2 positive signals and 3 negative signals. At the last closing, BIOINVENT INTERN. SK 2’s stock price was EUR 2.00. BIOINVENT INTERN. SK 2’s stock price has changed by +29.27% over the past week, +38.80% over the past month and -21.73% over the last year.

No recent analyst target price found for BIOINVENT INTERN. SK 2
No recent average analyst rating found for BIOINVENT INTERN. SK 2

Company Overview BIOINVENT INTERN. SK 2

BioInvent International AB (publ), a clinical-stage company, discovers, researches, and develops novel immuno-modulatory antibodies for the treatment of cancer in Sweden, Europe, the United States, and internationally. Its drug candidates are BI-1808 is in phase 2 clinical trial ...Read More

https://www.bioinvent.com

The Gamma Building, Lund, Sweden, 223 70

111

December

EUR

Germany

Adjusted Closing Price for BIOINVENT INTERN. SK 2 (BIX0:F)

Loading...

Unadjusted Closing Price for BIOINVENT INTERN. SK 2 (BIX0:F)

Loading...

Share Trading Volume for BIOINVENT INTERN. SK 2 Shares

Loading...

Compare Performance of BIOINVENT INTERN. SK 2 Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for BIX0:F

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To BIOINVENT INTERN. SK 2 (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NOVA:F
Novo Nordisk A/S +2.50 (+2.17%) EUR525.74B 45.80 4.49

ETFs Containing BIX0

Symbol Name BIX0's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About BIOINVENT INTERN. SK 2 (BIX0:F) Stock

Stock Target Advisor's fundamental analysis for BIOINVENT INTERN. SK 2's stock is Slightly Bearish.

Unfortunately we do not have enough data on BIX0:F's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on BIX0:F's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on BIX0:F's stock to indicate if its overvalued.

The last closing price of BIX0:F's stock was EUR 2.00.

The most recent market capitalization for BIX0:F is EUR 0.13B.

Unfortunately we do not have enough analyst data on BIX0:F's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains BIOINVENT INTERN. SK 2's stock.

As per our most recent records BIOINVENT INTERN. SK 2 has 111 Employees.

BIOINVENT INTERN. SK 2's registered address is The Gamma Building, Lund, Sweden, 223 70. You can get more information about it from BIOINVENT INTERN. SK 2's website at https://www.bioinvent.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...